Send Story by Email

Merck's New COVID Drug Is Making News -- How Does It Compare to Ivermectin?

10-10-2021 • Jeremy Loffredo

In his latest video, John Campbell, Ph.D., compared ivermectin, whose use as a COVID treatment has been widely criticized by mainstream media, with Merck's new COVID drug, Molnupiravir, which is garnering positive media coverage.

Your First Name

Your Last Name

Your Email Address

Enter one or more email addresses below. Separate multiple addresses with a semicolon (;) or a new line. Maximum 10 email addresses at one time.

To Email Address(es)

Personal Note

Also Send Daily Headlines Newsletter

Freedoms Phoenix

Online Magazine

Join-Us

Newspaper

Phone Apps

Declare Your Independence with Ernest Hancock

REAL TIME SPOT PRICES

Live Broadcast

Declare Your Independence

MENU

Send Story by Email

Merck's New COVID Drug Is Making News -- How Does It Compare to Ivermectin?

FreedomsPhoenix.com